TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
BIIB

Biogen Inc.

Healthcare · Drug Manufacturers - General

227.60$ +0.5% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

Biogen Inc. (BIIB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 449 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow BIIB
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
987 1,577 235 1,169 1,628 1,518 1,457 1,099 1,736 1,895 1,460 1,964 1,695 1,960 1,467 1,949 1,181 -367 769 1,227 805 838 162 737 661 -175 455 487 592 13 553 626 936 761 259 161 1,273 512 646 449 2,879
180 177 512 183 177 89 169 172 347 330 121 117 330 113 120 113 115 90 147 73 133 135 143 135 121 120 112 117 125 140 148 159 183 184 183 194 202 200 204 -204 402
34 37 37 34 30 31 43 38 37 39 46 52 46 38 68 44 38 49 70 54 56 59 68 56 64 67 76 74 62 55 73 71 73 75 81 75 75 60 84 -84 135
21 -23 131 -11 64 380 133 19 -125 270 336 -84 4.7 -2.0 221 238 50 166 111 -106 459 532 390 -1,416 -483 38 60 14 – – – – – – – – – – – – –
-245 775 -1,156 15 161 1,216 -16 -6.3 71 351 -147 263 -177 260 -328 93 183 -135 -331 226 -117 76 -781 880 -2.7 -988 -184 -131 314 -648 -229 -189 234 28 -334 -790 174 -109 -128 128 66
281 183 1,065 323 279 296 195 265 191 226 127 187 90 110 150 105 84 101 93 72 62 69 58 39 59 87 67 87 88 65 121 43 130 66 47 17 46 44 51 41 182
36 -582 -744 -203 -1,247 -770 1,347 -1,149 -619 -1,625 239 -111 -366 708 443 -833 -52 -166 -65 -153 -234 -113 -648 694 1,684 -141 -953 -752 -1,740 -644 -66 467 -1,181 -19 -47 -57 -35 -1,232 -210 -3,839 -5,316
0.0 0.0 303 0.0 0.0 1,355 0.0 39 2.0 0.5 – 4.3 – – – – – 71 – – – 1,622 – – 5.7 – – – – – – – – – – – – – – – –
-349 -651 -584 -782 0.0 1,365 -250 -2,750 2.0 -1,353 -656 -2,402 -718 -2,093 -2,220 -2,809 -1,250 -400 -600 -450 -750 1,800 0.2 -500 -250 750 0.2 1.5 0.0 0.0 – 9.3 -9.3 – – – – – – – –
-2.7 -2.7 -3.2 -3.2 -3.2 -558 -3.2 -3.2 – -3.2 – – 1,467 1,467 1,467 1,467 0.1 0.1 -169 -0.7 – -1,002 -1,002 -1,002 -1,002 – – – – – – – 0.0 0.0 0.0 -17 -0.3 0.0 – – –
-301 -721 -901 -751 -20 -708 -269 -2,792 25 -1,437 -679 -2,376 -689 -2,116 -2,245 -1,313 -1,313 -401 -785 -565 -747 9.8 -17 -472 -1,264 -7.6 -44 -11 846 -654 -440 -245 -6.6 7.9 -23 -12 -130 -137 -44 1,351 1,040
723 242 -1,403 246 379 26 2,534 -2,858 1,137 -1,162 1,019 -520 621 570 -322 -206 -160 -894 -114 525 -200 720 -512 897 1,029 -256 -521 -280 -330 -1,238 25 835 -210 676 223 161 1,104 -857 374 -2,043 -1,421
706 1,393 -830 846 1,349 1,223 1,252 835 1,545 1,670 1,332 1,777 1,605 1,850 1,318 1,844 1,097 -468 676 1,155 743 770 104 698 602 -262 389 400 505 -53 432 583 806 695 212 144 1,226 556 697 490 2,969

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?